<allTrials totalCount="1" xmlns="http://www.67bricks.com/isrctn"><fullTrial>
  <trial lastUpdated="2005-11-10T00:00:00.000Z" version="17">
    <isrctn dateAssigned="2005-11-10T00:00:00.000Z">28188789</isrctn>
    <trialDescription thirdPartyFilesAcknowledgement="false">
      <acknowledgment>true</acknowledgment>
      <title>Efficacy of a new Vitamin E foam in prevention of early skin damage in patients undergoing radiotherapy</title>
      <scientificTitle/>
      <acronym>VEFOAM</acronym>
      <studyHypothesis>To evaluate if a new topical formulation of Vitamin E is efficacious in the prevention of early skin damage during radiotherapy</studyHypothesis>
      <plainEnglishSummary>Not provided at time of registration</plainEnglishSummary>
      <primaryOutcome>1. Radiation Therapy Oncology Group (RTOG) skin score
2. Skin damage score</primaryOutcome>
      <secondaryOutcome>Tolerability</secondaryOutcome>
      <trialWebsite/>
      <ethicsApprovalRequired>Old ethics approval format</ethicsApprovalRequired>
      <ethicsCommittees/>
      <ethicsApproval>IRB approved study protocol in April 2004</ethicsApproval>
    </trialDescription>
    <externalRefs>
      <doi>10.1186/ISRCTN28188789</doi>
      <eudraCTNumber/>
      <irasNumber/>
      <clinicalTrialsGovNumber/>
      <protocolSerialNumber>VEF03/04</protocolSerialNumber>
    </externalRefs>
    <trialDesign>
      <studyDesign>Randomised parallel group Investigator blinded</studyDesign>
      <primaryStudyDesign>Interventional</primaryStudyDesign>
      <secondaryStudyDesign>Randomised controlled trial</secondaryStudyDesign>
      <trialSettings>
	<trialSetting>Not specified</trialSetting>
      </trialSettings>
      <trialTypes>
	<trialType>Prevention</trialType>
      </trialTypes>
      <overallStatusOverride/>
      <reasonAbandoned/>
      <overallStartDate>2004-03-01T00:00:00.000Z</overallStartDate>
      <overallEndDate>2005-06-01T00:00:00.000Z</overallEndDate>
    </trialDesign>
    <participants>
      <recruitmentCountries>
	<country>Italy</country>
      </recruitmentCountries>
      <trialCentres>
	<trialCentre id="ec2f28c1-27a3-4447-98dc-597c17fda6c0">
	  <name>Via A. Nota 18</name>
	  <address/>
	  <city>Milan</city>
	  <state/>
	  <country>Italy</country>
	  <zip>20126</zip>
	</trialCentre>
      </trialCentres>
      <participantTypes>
	<participantType>Patient</participantType>
      </participantTypes>
      <inclusion>Patients undergoing radiotherapy for breast or thoracic cancer</inclusion>
      <ageRange>Adult</ageRange>
      <gender>Female</gender>
      <targetEnrolment>80</targetEnrolment>
      <totalFinalEnrolment/>
      <totalTarget>80</totalTarget>
      <exclusion>Known sensibility to topical Vitamin E</exclusion>
      <patientInfoSheet/>
      <recruitmentStart>2004-03-01T00:00:00.000Z</recruitmentStart>
      <recruitmentEnd>2005-06-01T00:00:00.000Z</recruitmentEnd>
      <recruitmentStatusOverride/>
    </participants>
    <conditions>
      <condition>
	<description>Skin damage after radiotherapy</description>
	<diseaseClass1>Cancer</diseaseClass1>
	<diseaseClass2>Breast</diseaseClass2>
      </condition>
    </conditions>
    <interventions>
      <intervention>
	<description>Vitamin E foam topical application versus emollient standard cream</description>
	<interventionType>Supplement</interventionType>
	<pharmaceuticalStudyTypes/>
	<phase>Not Specified</phase>
	<drugNames>Vitamin E foam</drugNames>
      </intervention>
    </interventions>
    <results>
      <publicationPlan>Not provided at time of registration</publicationPlan>
      <ipdSharingStatement/>
      <dataPolicies>
	<dataPolicy>Not provided at time of registration</dataPolicy>
      </dataPolicies>
      <publicationDetails/>
      <publicationStage/>
      <biomedRelated>true</biomedRelated>
      <basicReport/>
      <plainEnglishReport/>
    </results>
    <outputs>
        
      </outputs>
    <parties>
      <funderId>Funder14188-0</funderId>
      <contactId>Contact51900_14188</contactId>
      <sponsorId>Sponsor50328</sponsorId>
    </parties>
    <miscellaneous xmlns:ssb="http://www.67bricks.com/isrctn/functions">
      <ipdSharingPlan>No</ipdSharingPlan>
    </miscellaneous>
    <attachedFiles/>
  </trial>
  <contact id="Contact51900_14188">
    <title>Dr</title>
    <forename>Massimo</forename>
    <surname>Milani</surname>
    <orcid/>
    <contactTypes xmlns:ssb="http://www.67bricks.com/isrctn/functions">
      <contactType>Scientific</contactType>
    </contactTypes>
    <contactDetails>
      <address>Via A. Nota 18</address>
      <city>Milan</city>
      <country>Italy</country>
      <zip>20126</zip>
      <telephone xmlns:ssb="http://www.67bricks.com/isrctn/functions">+39 (0)253548007</telephone>
      <email xmlns:ssb="http://www.67bricks.com/isrctn/functions">massimo.milani@mipharm.it</email>
    </contactDetails>
    <privacy>Public</privacy>
  </contact>
  <sponsor id="Sponsor50328">
    <organisation>Mipharm (Italy)</organisation>
    <website/>
    <sponsorType>Industry</sponsorType>
    <contactDetails>
      <address>Via B. Quaranta 12</address>
      <city>Milan</city>
      <country>Italy</country>
      <zip>20126</zip>
      <telephone xmlns:ssb="http://www.67bricks.com/isrctn/functions">+39 (0)253548007</telephone>
      <email xmlns:ssb="http://www.67bricks.com/isrctn/functions">massimo.milani@mipharm.it</email>
    </contactDetails>
    <privacy>Public</privacy>
    <gridId>grid.488329.c</gridId>
    <rorId>https://ror.org/0441v1872</rorId>
  </sponsor>
  <funder id="Funder14188-0">
    <name>Mipharm SPA</name>
    <fundRef/>
  </funder>
</fullTrial></allTrials>